Marshall Wace’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-28,462
Closed -$106K 4402
2021
Q3
$106K Sell
28,462
-162,958
-85% -$696K ﹤0.01% 2884
2021
Q2
$1.14M Buy
191,420
+128,610
+205% +$680K 0.01% 1746
2021
Q1
$414K Buy
62,810
+43,046
+218% +$283K ﹤0.01% 2016
2020
Q4
$111K Sell
19,764
-21,577
-52% -$118K ﹤0.01% 1795
2020
Q3
$194K Buy
+41,341
New +$293K ﹤0.01% 1459
2019
Q1
Sell
-6
Closed 2126
2018
Q4
$0 Buy
+6
New +$35 ﹤0.01% 1871

Other funds holding ARAV

Marshall Wace's ARAV Position: Q4 2021 in Review

Marshall Wace sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2021, closing a stake of 28,462 shares — an estimated $106K sold.

Marshall Wace first reported a position in ARAV in Q4 2018 and held it in 6 quarters. The position peaked at $1.14M in Q2 2021. 36 funds tracked by Wall St. Rank hold ARAV as of Q4 2021.

  • Marshall Wace reported no remaining Aravive, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Marshall Wace sold 28,462 Aravive, Inc. Common Stock shares in Q4 2021, an estimated $106K.
  • Marshall Wace first reported a position in Aravive, Inc. Common Stock in Q4 2018 and held it in 6 quarters.
  • Marshall Wace's Aravive, Inc. Common Stock position peaked at $1.14M in Q2 2021.
  • 36 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2021.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.